Health News Releases

May 17, 2022 11:10

Xlear Teams Up With Dr. Ferrer BioPharma to Bring a Better User Experience to Nasal Hygiene

Today Xlear announced a new partnership with Dr. Ferrer BioPharma (DFBP), which will make Xlear nasal spray the first nasal hygiene tool to deploy the GentleMist nozzle—the next generation nasal spray

May 16, 2022 09:30

Boehringer Ingelheim’s latest investigational treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis

Today, Boehringer Ingelheim announced Phase II data for BI 1015550, a novel investigational phosphodiesterase 4B (PDE4B) inhibitor, that was published in The New England Journal of Medicine (NEJM). Th

May 13, 2022 10:00

Update on the timeline for Vifor Pharma tender offer

Regulatory News: CSL Limited (ASX: CSL; USOTC:CSLLY) yesterday announced an update regarding the Vifor Pharma AG acquisition. CSL has previously advised that it expected to be in a position to clos

May 12, 2022 13:30

Takeda Delivers Strong FY2021 Results; Continued Growth Momentum Expected in FY2022

Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for fiscal year 2021 (period ended March 31, 2022), driven by the performance of its growth products, new product launches and str

May 11, 2022 15:20

Mawi DNA Technologies Launches NextSWAB™ For Accurate, More Reliable COVID-19 Test Results

Mawi DNA Technologies (Mawi), a medical device company focusing on the development of innovative technologies for biosampling, has launched the NextSWAB™, a 100% medical-grade plastic swab designed an

May 11, 2022 14:45

PCI Pharma Services Announces Major Manufacturing Expansion with $100 Million Investment in New England, Providing Global Capacity to Clients

PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced a major expansion of capabilities and capacity in aseptic liquid fill-finish and

May 10, 2022 10:30

TA Associates Announces Strategic Growth Investment in Zifo RnD Solutions

TA Associates (“TA”), a leading global growth private equity firm, today announced that the firm has completed a strategic growth investment in Zifo RnD Solutions (“Zifo”), a leading provider of scien

May 06, 2022 15:15

CureApp: World’s First Medical Device Regulatory Approval of Digital Therapeutic App for Hypertension

CureApp, Inc. (Head Office: Chuo-ku, Tokyo; CEO: Kohta Satake) was notified by the Ministry of Health, Labour and Welfare on April 26, 2022 that the company had received the medical device regulatory

May 06, 2022 09:40

Rhizen Pharmaceuticals AG Announces Promising Interim Data Presentation >From an Ongoing Phase II Study of Tenalisib (RP6530) in Locally Advanced or Metastatic Breast Cancer Patients At ESMO Breast Cancer Meeting 2022

Rhizen Pharmaceuticals AG (Rhizen), a Switzerland-based privately held, clinical-stage biopharmaceutical company announced today that it is presenting promising interim data from an ongoing Ph2 trial

May 04, 2022 15:35

Patient Safety Movement Foundation Announces Winners of 2021 Humanitarian and Lewis Blackman Awards

The Patient Safety Movement Foundation (PSMF), a global non-profit committed to achieving zero preventable patient deaths by 2030, announced the winners of its 2021 Humanitarian and Lewis Blackman awa

May 02, 2022 13:40

Groundbreaking research cooperation: The Medi-Globe Group and the IHU in Strasbourg are developing the world‘s first AI software for detecting pancreatic diseases

The Medi-Globe Group has entered into a groundbreaking research cooperation with the French Institut Hospitalo-Universitaire (IHU) in Strasbourg. The goal of the collaboration is the world‘s first AI

April 28, 2022 15:30

Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220427005801/en/ Vifor Fresenius Medical Care Renal Pharma (VFMCRP)

April 27, 2022 17:25

94th Vifor Pharma Group Annual General Meeting

Regulatory News: At today’s 94th Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors. The Annual General Meeting was ag

April 27, 2022 16:30

Takeda Recognized as the 2022 ISPE Facility of the Year Awards Winner in Two Categories

Takeda (TSE:4502/NYSE:TAK) today announced that the International Society for Pharmaceutical Engineering (ISPE) has awarded the company top honors in the Supply Chain and Pharma 4.0™ categories for th

April 26, 2022 16:15

GemPharmatech, Leading Provider of Genetically Engineered Mouse Models, Goes Public on Shanghai Stock Exchange

GemPharmatech LLC is pleased to announce that on April 25, 2022, its parent company, GemPharmatech Co., Ltd., went public on the STAR MARKET of the Shanghai Stock Exchange under the stock code 688046.

April 26, 2022 14:05

Mawi iSWAB Microbiome-EL Enables Prime Discoveries’ Development of Rapid Extraction-Less COVID Diagnostic Assay

Mawi DNA Technologies (Mawi), a biotechnology company focusing on the development of innovative technologies for biosampling, announces that Prime Discoveries has successfully developed CovidDetect™,

April 25, 2022 11:30

Takeda Presents New Exploratory Analysis Showing Patients Treated With LIVTENCITY™ (Maribavir) Had Reductions in Hospitalization Rates and Length of Hospital Stay

Takeda (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it will present four company-sponsored abstracts at the Tandem Transplantation & Cellular Therapy Meetings in Salt Lake City, Utah, and the 3

April 21, 2022 17:20

Boehringer Ingelheim launches RenuTend™: a new stem cell therapy to improve the healing of tendon and suspensory ligament injuries in horses

It takes years of diligent training as well as a trusting relationship between horse and rider to reach their full potential as a team. That’s why a tendon or ligament injury can be devastating for ho

April 21, 2022 14:10

How Cloud Deployment In Big Data Analytics In Healthcare Industry Led To Gain Immense Traction In Asia Pacific: Fact.MR

According to the Fact.MR’s Latest Study, the global demand for big data analytics in healthcare is estimated at US$ 39.7 billion in 2022. Data as a technology has been adopted by healthcare industry s

April 19, 2022 16:30

Takeda Announces Approval of Nuvaxovid® COVID-19 Vaccine for Primary and Booster Immunization in Japan

Takeda (TSE:4502/NYSE:TAK) today announced that it has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for Nuvaxovid® Intramuscular Injection

April 19, 2022 15:00

Surging Hospitalization Rates For Numerous Chronic And Infectious Ailments Are Driving Demand For Hospital Supplies Market: Fact.MR

According to the latest Fact.MR analysis, the global hospital supplies market is predicted to grow at a CAGR of over 3%, reaching US$ 23 Bn by the end of the 2021-2031 forecast period, concludes Fact.

April 15, 2022 14:30

Kaneka Launches New PCR Test Kit for Identifying the COVID-19 Omicron (BA.1) and “Stealth” Omicron (BA.2) Variants

On March 31, Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) released KANEKA RT-PCR Kit “SARS-CoV-2 (Omicron/Delta) ver.2”, a real-time PCR test kit capable of simultaneo

April 15, 2022 14:15

Advanced Clinical Continues Global Expansion Into Europe With New Office in Switzerland

Advanced Clinical, a clinical development and strategic resourcing organization, is pleased to announce its continued expansion into Europe with the opening of a new office in Zug, Switzerland. “We

April 15, 2022 09:30

Advancement In Oxygen Concentrators Industry Drives Revenue Share Upsurge By 2031... Projected To Top USD 5 Bn: Fact.MR's Latest Survey

As per a new report published by Fact.MR - Market research and competitive intelligence provider, the market for medical oxygen systems is anticipated to top US$ 5 Bn by 2031 and expand at a CAGR of 7

April 14, 2022 10:30

Takeda Announces Completion of Acquisition of Own Shares

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today provided an update on the status and announced the completion of the acquisition of its own shares, which has been carried

News by Region

News by Industry